Australia markets closed

Evaxion Biotech A/S (EVAX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0200+0.0500 (+1.68%)
At close: 04:00PM EST
3.0200 0.00 (0.00%)
After hours: 07:11PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.9700
Bid2.8200 x 1300
Ask3.0200 x 800
Day's range2.8200 - 3.0400
52-week range2.8000 - 25.0400
Avg. volume963,352
Market cap69.887M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.1240
Earnings date04 Apr 2022 - 08 Apr 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.25
  • GlobeNewswire

    Evaxion Biotech Announces Publication of Clinical Data of EVX-01 Heading into Phase 2b in Collaboration with Merck

    COPENHAGEN, Denmark, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the publication of a paper on personalized therapy with EVX-01 in patients with metastatic melanoma in the open access, peer-reviewed journal OncoImmunology. The paper, entitled, “Personalized therapy with peptide-based neo

  • Zacks

    Evaxion Biotech AS Sponsored ADR (EVAX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

    After losing some value lately, a hammer chart pattern has been formed for Evaxion Biotech AS Sponsored ADR (EVAX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

  • GlobeNewswire

    Nasdaq’s European Markets Delivered Record Year in 2021

    - Solidified Nasdaq position as the leading European listings hub with 219 new equity listings, including a record number of 174 initial public offerings (IPOs), raising a total of EUR 13.4 billion- Retail inflow and large interest in SME trading spurred all-time high levels in equity and derivative trading- Continued to lead in ESG with venture investment in and new product launches STOCKHOLM, Sweden, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today that Nasdaq